NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · Real-Time Price · USD
0.3560
-0.0034 (-0.95%)
Apr 25, 2025, 4:00 PM EDT - Market closed

NewGenIvf Group Statistics

Total Valuation

NewGenIvf Group has a market cap or net worth of $594,645. The enterprise value is $2.25 million.

Market Cap 594,645
Enterprise Value 2.25M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

NewGenIvf Group has 1.70 million shares outstanding. The number of shares has increased by 2,316.76% in one year.

Current Share Class 1.70M
Shares Outstanding 1.70M
Shares Change (YoY) +2,316.76%
Shares Change (QoQ) +185.91%
Owned by Insiders (%) 15.62%
Owned by Institutions (%) 7.13%
Float 1.40M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.02
Forward PS n/a
PB Ratio -0.40
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.41
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.17

Current Ratio 1.17
Quick Ratio 1.06
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.49

Financial Efficiency

Return on equity (ROE) is -53.76% and return on invested capital (ROIC) is -27.47%.

Return on Equity (ROE) -53.76%
Return on Assets (ROA) -17.99%
Return on Invested Capital (ROIC) -27.47%
Return on Capital Employed (ROCE) -135.35%
Revenue Per Employee $77,620
Profits Per Employee -$7,495
Employee Count 70
Asset Turnover 1.35
Inventory Turnover 34.83

Taxes

Income Tax -486,706
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.85% in the last 52 weeks. The beta is 0.17, so NewGenIvf Group's price volatility has been lower than the market average.

Beta (5Y) 0.17
52-Week Price Change -98.85%
50-Day Moving Average 1.11
200-Day Moving Average 9.94
Relative Strength Index (RSI) 29.11
Average Volume (20 Days) 6,211,446

Short Selling Information

The latest short interest is 142,106, so 8.37% of the outstanding shares have been sold short.

Short Interest 142,106
Short Previous Month 189,420
Short % of Shares Out 8.37%
Short % of Float 10.18%
Short Ratio (days to cover) 0.25

Income Statement

In the last 12 months, NewGenIvf Group had revenue of $5.43 million and -$524,643 in losses. Loss per share was -$1.47.

Revenue 5.43M
Gross Profit 1.83M
Operating Income -1.16M
Pretax Income n/a
Net Income -524,643
EBITDA -1.14M
EBIT -1.16M
Loss Per Share -$1.47
Full Income Statement

Balance Sheet

The company has $1.53 million in cash and $3.18 million in debt, giving a net cash position of -$1.65 million or -$0.97 per share.

Cash & Cash Equivalents 1.53M
Total Debt 3.18M
Net Cash -1.65M
Net Cash Per Share -$0.97
Equity (Book Value) -1.48M
Book Value Per Share -0.92
Working Capital 452,391
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.26 million and capital expenditures -$53,045, giving a free cash flow of -$8.32 million.

Operating Cash Flow -8.26M
Capital Expenditures -53,045
Free Cash Flow -8.32M
FCF Per Share -$4.90
Full Cash Flow Statement

Margins

Gross margin is 33.62%, with operating and profit margins of -21.36% and -9.66%.

Gross Margin 33.62%
Operating Margin -21.36%
Pretax Margin -17.68%
Profit Margin -9.66%
EBITDA Margin -21.00%
EBIT Margin -21.36%
FCF Margin n/a

Dividends & Yields

NewGenIvf Group does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2,316.76%
Shareholder Yield -2,316.76%
Earnings Yield -88.23%
FCF Yield -1,398.67%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on February 11, 2025. It was a reverse split with a ratio of 0.05:1.

Last Split Date Feb 11, 2025
Split Type Reverse
Split Ratio 0.05:1

Scores

NewGenIvf Group has an Altman Z-Score of 1.86 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.86
Piotroski F-Score 1